Moderna, Inc. [MRNA] - appoints Michael McDonnell as Director
Effective July 8, 2026, Michael McDonnell was appointed as a Class II director and member of the Audit Committee at Moderna, Inc., succeeding David Rubenstein who transitioned to the Nominating and Corporate Governance Committee.
Why this matters
Generating analysis…